EP 1233771 A4 20030514 - PROTEASE INHIBITORS
Title (en)
PROTEASE INHIBITORS
Title (de)
PROTEASEHEMMER
Title (fr)
INHIBITEURS DE PROTEASE
Publication
Application
Priority
- US 0030681 W 20001108
- US 16480099 P 19991110
Abstract (en)
[origin: WO0134155A1] The invention relates to the compound of Formula (I) or a pharmaceutically acceptable salt, hydrate or solvate thereof, which is an inhibitor of cysteine proteases, particularly cathepsin K, and is useful in the treatment of diseases in which inhibition of bone loss or of cartilage degradation is a factor.
IPC 1-7
IPC 8 full level
C07D 405/12 (2006.01); A61K 31/55 (2006.01); A61P 1/02 (2006.01); A61P 19/02 (2006.01); A61P 19/08 (2006.01); A61P 19/10 (2006.01); A61P 29/00 (2006.01); A61P 43/00 (2006.01); C07D 405/14 (2006.01)
CPC (source: EP)
A61K 31/55 (2013.01); A61P 1/02 (2018.01); A61P 19/02 (2018.01); A61P 19/08 (2018.01); A61P 19/10 (2018.01); A61P 29/00 (2018.01); A61P 43/00 (2018.01); C07D 405/14 (2013.01); Y02A 50/30 (2018.01)
Citation (search report)
[X] WO 9805336 A1 19980212 - SMITHKLINE BEECHAM CORP [US], et al
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0134155 A1 20010517; AU 1474601 A 20010606; EP 1233771 A1 20020828; EP 1233771 A4 20030514; JP 2003513923 A 20030415
DOCDB simple family (application)
US 0030681 W 20001108; AU 1474601 A 20001108; EP 00977055 A 20001108; JP 2001536153 A 20001108